<DOC>
	<DOCNO>NCT02958267</DOCNO>
	<brief_summary>The purpose study determine clinical response autologous bone marrow aspirate concentrate ( BMAC ) platelet-rich plasma ( PRP ) injection knee osteoarthritis respect pain , function , quality life 1 year follow intervention . Specifically , clinical response compare baseline control group treat Gel-One® hyaluronate injection target knee .</brief_summary>
	<brief_title>Investigation Mesenchymal Stem Cell Therapy Treatment Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Male female patient 40 70 year old 2 . Diagnosed knee osteoarthritis base American College Rheumatology criterion include symptomatic report radiographic finding 3 . KellgrenLawrence grade 13 base radiograph within 6 month presentation clinic 4 . Symptomatic evidence tibiofemoral osteoarthritis ≥6 month 5 . Average numeric pain rating 4 8 scale zero 10 ( define moderate level ) past week 6 . Previous trial 6 week minimum conservative therapy include physical therapy , weight loss , antiinflammatory medication , injection therapy 1 . Grade 4 knee osteoarthritis accord KellgrenLawrence scale 2 . History intraarticular viscosupplementation steroid injection target knee past 6 month time baseline visit intraarticular injection plan trial 3 . History arthroscopic surgery target knee past 12 month time presentation clinic plan surgery trial period ( e.g. , schedule for/awaiting arthroscopy knee replacement procedure ) 4 . Bilateral knee osteoarthritis ( unless contralateral knee involvement limit radiographic osteoarthritis symptomatic ) 5 . Ipsilateral ( side ) contralateral ( opposite side ) symptomatic osteoarthritis hip ankle 6 . Clinically apparent tense effusion acute inflammation target knee time presentation clinic 7 . Active infection either low extremity cellulitis skin disease infection area BMAC aspirate , blood drawn , injection give 8 . History diagnosis following : 1 ) septic osteoarthritis joint , 2 ) inflammatory arthropathy rheumatoid arthritis , gout , pseudogout , lupus , crystalline arthropathy , chondrocalcinosis rheumatology diagnose 9 . Cruciate/collateral knee ligament instability , ligament laxity , meniscal instability target knee 10 . Significant alignment deformity varus/valgus target knee judgment investigator 11 . Currently pregnant , nursing , plan become pregnant trial period 12 . Previous know allergic reaction hypersensitivity heparin ; sodium citrate ; hyaluronan product specifically GelOne® ; cinnamon ; bird product feather , egg , poultry ; avian proteins 13 . Not suitable BMAC tissue allograft injection per physician ( e.g. , blood dyscrasia ) 14 . Unable prescribed stable dose NSAIDs and/or tramadol base medical history ad lib use overthecounter analgesic allow group treatment 15 . Current cigarette smoker 16 . Unable give inform consent 17 . NonEnglish speaking</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>knee osteoarthritis</keyword>
	<keyword>regenerative medicine</keyword>
	<keyword>orthobiologics</keyword>
	<keyword>cellular therapy</keyword>
</DOC>